PHASE-II CLINICAL-STUDY OF HIGH-DOSE TOREMIFENE IN PATIENTS WITH ADVANCED BREAST-CANCER

被引：8
|
作者：
MODIG, H
BORGSTROM, S
NILSSON, I
WESTMAN, G
机构：
[1] MALMO GEN HOSP,DEPT ONCOL,S-21401 MALMO,SWEDEN
[2] OREBRO REG HOSP,DEPT ONCOL,OREBRO,SWEDEN
来源：
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY | 1990年 / 36卷 / 03期
关键词：
D O I：
10.1016/0022-4731(90)90015-K
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
Thirteen postmenopausal women with advanced local or metastatic breast cancer were treated with the antiestrogen toremifene at a daily dose of 200 mg. All patients had failed previous treatment with different types of endocrine therapy and/or cytotoxic drugs. Objective response was only seen in one patient. Treatment was usually well tolerated but in three cases the drug had to be withdrawn due to side effects. © 1990.
引用
收藏
页码：237 / 238
页数：2
相关论文
共 50 条
  • [31] PHASE-II STUDY OF INTRAVENOUS MENOGARIL IN PATIENTS WITH ADVANCED BREAST-CANCER
    SESSA, C
    GUNDERSEN, S
    HUININK, WT
    RENARD, J
    CAVALLI, F
    JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1988, 80 (13) : 1066 - 1069
  • [32] PHASE-II STUDY OF ANGUIDINE IN ADVANCED BREAST-CANCER
    YAP, HY
    MURPHY, WK
    DISTEFANO, A
    BLUMENSCHEIN, GR
    BODEY, GP
    CANCER TREATMENT REPORTS, 1979, 63 (05): : 789 - 791
  • [33] IDARUBICIN IN ADVANCED BREAST-CANCER - A PHASE-II STUDY
    LIONETTO, R
    PRONZATO, P
    CONTE, PF
    SERTOLI, MR
    AMOROSO, D
    ROSSO, R
    CANCER TREATMENT REPORTS, 1986, 70 (12): : 1439 - 1440
  • [34] A PHASE-II STUDY OF MITOXANTRONE IN ADVANCED BREAST-CANCER
    PRONZATO, P
    ARDIZZONI, A
    CONTE, PF
    GULISANO, M
    LIONETTO, R
    REPETTO, L
    SCORNAVACCHE, V
    SERTOLI, MR
    ROSSO, R
    CHEMIOTERAPIA, 1986, 5 (03): : 150 - 153
  • [35] PHASE-II STUDY OF TENIPOSIDE IN ADVANCED BREAST-CANCER
    BOAS, J
    RASMUSSEN, D
    HANSEN, OP
    ENGELHOLM, SA
    DOMBERNOWSKY, P
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1990, 25 (06) : 463 - 464
  • [36] VINCRISTINE WITH HIGH-DOSE ETOPOSIDE IN ADVANCED BREAST-CANCER - A PHASE-II TRIAL OF THE PIEDMONT-ONCOLOGY-ASSOCIATION
    THOMAS, GW
    MUSS, HB
    JACKSON, DV
    MCCULLOCH, J
    RAMSEUR, W
    MCFARLAND, J
    HOEN, H
    PAVY, M
    HEATH, R
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1994, 35 (02) : 165 - 168
  • [37] A PHASE-II STUDY OF 5-FLUOROURACIL AND HIGH-DOSE FOLINIC ACID IN COMBINATION WITH CYCLOPHOSPHAMIDE AND MITOXANTRONE FOR ADVANCED BREAST-CANCER
    AITINI, E
    CAVAZZINI, G
    CANTORE, M
    RABBI, C
    RIVERA, A
    TOGLIANI, B
    DIMARCO, A
    SMERIERI, F
    EUROPEAN JOURNAL OF CANCER, 1992, 28A (12) : 1968 - 1970
  • [38] CLINICAL AND PHARMACOLOGICAL STUDY OF HIGH-DOSE MEDROXYPROGESTERONE ACETATE IN PATIENTS WITH ADVANCED BREAST-CANCER
    BECHER, R
    MILLER, AA
    GERHOLD, U
    HOFFKEN, K
    SCHMIDT, CG
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1985, 26 (MAR): : 191 - 191
  • [39] HIGH-DOSE TOREMIFENE IN ADVANCED BREAST-CANCER RESISTANT TO OR RELAPSED DURING TAMOXIFEN TREATMENT
    PYRHONEN, S
    VALAVAARA, R
    VUORINEN, J
    HAJBA, A
    BREAST CANCER RESEARCH AND TREATMENT, 1994, 29 (03) : 223 - 228
  • [40] PHASE-II EVALUATION OF VINDESINE IN PATIENTS WITH ADVANCED BREAST-CANCER
    CURRIE, VE
    CAMACHO, F
    WITTES, R
    YOUNG, C
    CANCER TREATMENT REPORTS, 1980, 64 (4-5): : 693 - 695
12345